| 5001 | EIF4B levels | GCST90469094 | 1.72 |
| 5002 | Worry too long after an embarrassing experience | GCST006946 | 1.71 |
| 5003 | Heel bone mineral density | GCST006288 | 1.71 |
| 5004 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T318 | ECGU000318 | 1.71 |
| 5005 | Nonalcoholic fatty liver disease | GCST90054782 | 1.71 |
| 5006 | USO1 levels | GCST90471018 | 1.71 |
| 5007 | BACH1/PDLIM7 ratio | GCST90313445 | 1.71 |
| 5008 | FHIT/PRTFDC1 ratio | GCST90314823 | 1.71 |
| 5009 | Phospholipids in small HDL | GCST90499483 | 1.70 |
| 5010 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T449 | ECGA000449 | 1.70 |
| 5011 | Gestational [pregnancy-induced] oedema and proteinuria without hypertension | FING00000572 | 1.70 |
| 5012 | FURIN/PLA2G15 ratio | GCST90314887 | 1.70 |
| 5013 | CSRP3 levels | GCST90468892 | 1.70 |
| 5014 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 1.70 |
| 5015 | PPBP levels | GCST90470289 | 1.70 |
| 5016 | ADM levels | GCST90011996 | 1.70 |
| 5017 | F-sauces liking (derived food-liking factor) | GCST90094831 | 1.70 |
| 5018 | Fasting blood insulin | GCST005185 | 1.70 |
| 5019 | PDCD1/TNFRSF8 ratio | GCST90315610 | 1.70 |
| 5020 | HippSubfield rh volume subiculum-head | GCST90002693 | 1.70 |
| 5021 | Sleeplessness / insomnia | Sleep | UKBB00000778 | 1.70 |
| 5022 | 1-palmitoylglycerophosphoethanolamine levels | GCST90243835 | 1.70 |
| 5023 | DPP6/NRCAM ratio | GCST90314542 | 1.70 |
| 5024 | Omega-6 fatty acid levels | GCST90502515 | 1.70 |
| 5025 | Body mass index | GCST90502912 | 1.69 |
| 5026 | TNFRSF10C levels | GCST90470901 | 1.69 |
| 5027 | KLRB1 levels | GCST90469709 | 1.69 |
| 5028 | BACH1/SNAP23 ratio | GCST90313446 | 1.69 |
| 5029 | DAG1 levels | GCST90468943 | 1.68 |
| 5030 | 1-arachidonoylglycerophosphocholine levels | GCST90243674 | 1.68 |
| 5031 | Tea with sugar liking | GCST90094857 | 1.68 |
| 5032 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 1.68 |
| 5033 | Cognitive performance | GCST006572 | 1.68 |
| 5034 | BACH1/EIF4G1 ratio | GCST90313438 | 1.68 |
| 5035 | Triglycerides to total lipids ratio in medium LDL | GCST90092915 | 1.68 |
| 5036 | Peripheral vascular disease | GCST90086134 | 1.68 |
| 5037 | Hidradenitis suppurativa | FING00000621 | 1.68 |
| 5038 | Idiopathic pulmonary fibrosis | GCST90399720 | 1.68 |
| 5039 | AP3B1 levels | GCST90468325 | 1.68 |
| 5040 | Biliverdin levels in chronic kidney disease | GCST90257495 | 1.68 |
| 5041 | YTHDF3 levels | GCST90471091 | 1.68 |
| 5042 | IDP dMRI TBSS FA Sagittal stratum L | GCST90003908 | 1.68 |
| 5043 | Total bilirubin levels | GCST90278643 | 1.68 |
| 5044 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101 | ECGU000101 | 1.68 |
| 5045 | Alanine aminotransferase | Blood biochemistry | UKBB00000018 | 1.68 |
| 5046 | IDP dMRI ProbtrackX MD ifo r | GCST90004232 | 1.68 |
| 5047 | CD300LG/DSG2 ratio | GCST90313802 | 1.67 |
| 5048 | Ulcerative colitis | GCST90468152 | 1.67 |
| 5049 | rfMRI connectivity (ICA100 edge 619) | GCST90005472 | 1.67 |
| 5050 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T388 | ECGU000388 | 1.67 |
| 5051 | IDP dMRI ProbtrackX L3 ptr l | GCST90004319 | 1.67 |
| 5052 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T453 | ECGA000453 | 1.67 |
| 5053 | IDP dMRI ProbtrackX FA slf r | GCST90003947 | 1.67 |
| 5054 | SSC4D levels | GCST90470747 | 1.67 |
| 5055 | aparc-Desikan rh area superiorparietal | GCST90003135 | 1.67 |
| 5056 | rfMRI amplitudes (ICA100 node 28) | GCST90004616 | 1.67 |
| 5057 | SERPINF2 levels | GCST90470599 | 1.67 |
| 5058 | Main speciality of consultant (recoded) - Cardiology | Summary Administration | UKBB00000414 | 1.67 |
| 5059 | FXN/TRIAP1 ratio | GCST90314899 | 1.67 |
| 5060 | SUSD2 levels | GCST90470787 | 1.67 |
| 5061 | Right ventricular ejection fraction | GCST90134591 | 1.67 |
| 5062 | APOL1 levels | GCST90468341 | 1.67 |
| 5063 | SLAMF7 levels | GCST90470651 | 1.67 |
| 5064 | CD164/PARK7 ratio | GCST90313743 | 1.66 |
| 5065 | 2s,3R-dihydroxybutyrate levels | GCST90199882 | 1.66 |
| 5066 | IPCEF1/TBCC ratio | GCST90315188 | 1.66 |
| 5067 | Psoriatic arthropathies | FING00001225 | 1.66 |
| 5068 | FCRL6/KLRD1 ratio | GCST90314807 | 1.66 |
| 5069 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T95 | ECGA000095 | 1.66 |
| 5070 | DNAJA2 levels | GCST90469009 | 1.66 |
| 5071 | IGFBP6/SMOC2 ratio | GCST90315138 | 1.66 |
| 5072 | Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00001143 | 1.66 |
| 5073 | Lactate levels | GCST90092882 | 1.66 |
| 5074 | aparc-Desikan rh area precentral | GCST90003130 | 1.66 |
| 5075 | IDP dMRI TBSS L2 Anterior corona radiata L | GCST90004146 | 1.66 |
| 5076 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361 | ECGA000361 | 1.66 |
| 5077 | Reaction time | GCST003499 | 1.66 |
| 5078 | FADD/PLIN3 ratio | GCST90314772 | 1.66 |
| 5079 | Alpha angle | GCST90129635 | 1.65 |
| 5080 | Glucose levels (UKB data field 23470) | GCST90269567 | 1.65 |
| 5081 | COPD-related respiratory insufficiency | FING00000352 | 1.65 |
| 5082 | aparc-Desikan lh area parstriangularis | GCST90003092 | 1.65 |
| 5083 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T489 | ECGU000489 | 1.65 |
| 5084 | DAG1/PDGFB ratio | GCST90314379 | 1.65 |
| 5085 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T227 | ECGU000227 | 1.65 |
| 5086 | SHBG levels | GCST90470622 | 1.65 |
| 5087 | CLEC1A/GPR37 ratio | GCST90314084 | 1.65 |
| 5088 | ITGB1BP2/LAT2 ratio | GCST90315212 | 1.65 |
| 5089 | Other maternal disorders predominantly related to pregnancy | FING00001069 | 1.64 |
| 5090 | Oral glucose tolerance test-1h | GCST90566422 | 1.64 |
| 5091 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455 | ECGA000455 | 1.64 |
| 5092 | BA-exvivo lh thickness BA4a | GCST90003517 | 1.64 |
| 5093 | F-salty food liking (derived food-liking factor) | GCST90094827 | 1.64 |
| 5094 | Physical activity (Total log acceleration 10pm-12am) | GCST90061420 | 1.64 |
| 5095 | DKK1/IPCEF1 ratio | GCST90314471 | 1.64 |
| 5096 | ZNRD2 levels | GCST90471103 | 1.64 |
| 5097 | HEXIM1/TRIAP1 ratio | GCST90315054 | 1.64 |
| 5098 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T450 | ECGA000450 | 1.64 |
| 5099 | CCL5/RARRES2 ratio | GCST90313704 | 1.64 |
| 5100 | TARBP2/TDRKH ratio | GCST90315902 | 1.64 |
| 5101 | MTDH levels | GCST90469954 | 1.63 |
| 5102 | CD46/NID1 ratio | GCST90313833 | 1.63 |
| 5103 | T1 FreeSurfer a2009s rh G cuneus area | GCST90384900 | 1.63 |
| 5104 | CD34 levels | GCST90468626 | 1.63 |
| 5105 | BCAM/SEMA7A ratio | GCST90313476 | 1.63 |
| 5106 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T451 | ECGA000451 | 1.63 |
| 5107 | Nontoxic multinodular goitre | FING00000888 | 1.63 |
| 5108 | NECTIN2/TNFRSF14 ratio | GCST90315531 | 1.63 |
| 5109 | Skin sebum (glabella) | GCST90502797 | 1.63 |
| 5110 | DTI autoptx L2 unc l tract | GCST90385191 | 1.63 |
| 5111 | aseg rh volume Pallidum | GCST90002640 | 1.63 |
| 5112 | L3HYPDH levels | GCST90469724 | 1.62 |
| 5113 | TIMP3/ZBTB16 ratio | GCST90315921 | 1.62 |
| 5114 | VNN1 levels | GCST90471043 | 1.62 |
| 5115 | CXCL3/CXCL5 ratio | GCST90314344 | 1.62 |
| 5116 | Cigarettes smoked per day (MTAG) | GCST90179151 | 1.62 |
| 5117 | CDKN1A/NCK2 ratio | GCST90313973 | 1.62 |
| 5118 | NFATC1/TJAP1 ratio | GCST90315540 | 1.62 |
| 5119 | Malignant melanoma of skin, excluding all cancers (controls excluding all cancers) | FING00000749 | 1.62 |
| 5120 | NPC2 levels | GCST90470068 | 1.62 |
| 5121 | Histidine levels | GCST90497479 | 1.62 |
| 5122 | IDP dMRI ProbtrackX MD cgc r | GCST90004224 | 1.62 |
| 5123 | CD74/NPDC1 ratio | GCST90313895 | 1.62 |
| 5124 | CLC levels | GCST90468762 | 1.62 |
| 5125 | CHAC2 levels | GCST90468736 | 1.62 |
| 5126 | Mean corpuscular hemoglobin concentration | GCST90002329 | 1.62 |
| 5127 | DAG1/SCARF1 ratio | GCST90314381 | 1.61 |
| 5128 | Abnormal results of function study of liver (PheCode 573.7) | GCST90476097 | 1.61 |
| 5129 | Diacylglycerol_34:1_[M+H-H2O]1+ levels | GCST90060179 | 1.61 |
| 5130 | JAM2/THBD ratio | GCST90315239 | 1.61 |
| 5131 | Hypothyroidism | GCST90468138 | 1.61 |
| 5132 | CD40 levels | GCST90012065 | 1.61 |
| 5133 | Right-hemisphere somatomotor network to putamen white-matter structural connectivity | GCST90302796 | 1.61 |
| 5134 | Disorders of bilirubin excretion (PheCode 277.4) | GCST90475756 | 1.61 |
| 5135 | Number of puzzles correctly solved (baseline) | GCST90565840 | 1.61 |
| 5136 | GGCT levels | GCST90469334 | 1.60 |
| 5137 | PVR levels | GCST90470394 | 1.60 |
| 5138 | Alanine aminotransferase levels | GCST90025979 | 1.60 |
| 5139 | LGALS1 levels | GCST90469759 | 1.60 |
| 5140 | Later onset COPD | FING00000714 | 1.60 |
| 5141 | ADGRG2/SDC1 ratio | GCST90313187 | 1.60 |
| 5142 | CHI3L1 levels | GCST90468743 | 1.60 |
| 5143 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 1.60 |
| 5144 | PLAT levels | GCST90470250 | 1.59 |
| 5145 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277 | ECGU000277 | 1.59 |
| 5146 | Gastric ulcer | GCST90018631 | 1.59 |
| 5147 | PDGFA/SERPINE1 ratio | GCST90315618 | 1.59 |
| 5148 | T1 FreeSurfer aseg CC Posterior | GCST90384175 | 1.59 |
| 5149 | MGLL/PLA2G4A ratio | GCST90315439 | 1.58 |
| 5150 | Clonal hematopoiesis (DNMT3A mutation) | GCST90435354 | 1.58 |
| 5151 | CRTAM/PDCD1 ratio | GCST90314279 | 1.58 |
| 5152 | HippSubfield rh volume presubiculum-head | GCST90002695 | 1.58 |
| 5153 | Fruit liking | GCST90094766 | 1.58 |
| 5154 | CDKN1A/YES1 ratio | GCST90313980 | 1.58 |
| 5155 | DSG3/FABP9 ratio | GCST90314559 | 1.58 |
| 5156 | Early-onset myasthenia gravis | GCST90093465 | 1.58 |
| 5157 | Turnip liking | GCST90094861 | 1.58 |
| 5158 | Hair colour (natural, before greying) - Blonde | Sun exposure | UKBB00000296 | 1.58 |
| 5159 | Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132931 | 1.58 |
| 5160 | CD22/CD79B ratio | GCST90313755 | 1.58 |
| 5161 | ANGPT1/CCN2 ratio | GCST90313261 | 1.57 |
| 5162 | CLEC1A levels | GCST90468767 | 1.57 |
| 5163 | Acceptance of an invitation to wear a physical activity monitor | GCST90012791 | 1.57 |
| 5164 | ENTPD5 levels | GCST90241024 | 1.57 |
| 5165 | GSTT2 levels | GCST90086652 | 1.57 |
| 5166 | Hippocampal right HATA volume | GCST90267969 | 1.57 |
| 5167 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T424 | ECGA000424 | 1.57 |
| 5168 | C2/SSC5D ratio | GCST90313555 | 1.57 |
| 5169 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T422 | ECGA000422 | 1.57 |
| 5170 | Lamb liking | GCST90094790 | 1.57 |
| 5171 | Colitis, primary sclerosing, strict definition | FING00000313 | 1.57 |
| 5172 | Cholesterol to total lipids in large VLDL percentage (UKB data field 23590) | GCST90269687 | 1.56 |
| 5173 | Multi-trait sum score | GCST90270117 | 1.56 |
| 5174 | Oral glucose tolerance test-2h | GCST90566423 | 1.56 |
| 5175 | Varicose veins (PheCode 454) | GCST90476012 | 1.56 |
| 5176 | Type 1 diabetes | GCST90432066 | 1.56 |
| 5177 | BAMBI levels | GCST90468420 | 1.56 |
| 5178 | N-acetylcarnosine levels | GCST90199926 | 1.56 |
| 5179 | Triglycerides in very large VLDL | GCST90500680 | 1.56 |
| 5180 | INHBB levels | GCST90469614 | 1.56 |
| 5181 | IDP dMRI TBSS L3 Posterior thalamic radiation L | GCST90004200 | 1.56 |
| 5182 | PPP1R12A/TXNDC5 ratio | GCST90315714 | 1.56 |
| 5183 | CD99/CD99L2 ratio | GCST90313923 | 1.56 |
| 5184 | HNRNPK levels | GCST90469469 | 1.55 |
| 5185 | eosinophil (fraction, minimum, inv-norm transformed) | GCST90475303 | 1.55 |
| 5186 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T370 | ECGU000370 | 1.55 |
| 5187 | CCL2 levels | GCST90012007 | 1.55 |
| 5188 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T423 | ECGA000423 | 1.55 |
| 5189 | RAB27B levels | GCST90470405 | 1.55 |
| 5190 | CD244/CD84 ratio | GCST90313762 | 1.55 |
| 5191 | CD84/SEMA4D ratio | GCST90313917 | 1.55 |
| 5192 | Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602) | GCST90269699 | 1.55 |
| 5193 | Spondylopathies (FG) | FING00001326 | 1.55 |
| 5194 | 3,5-dichloro-2,6-dihydroxybenzoic acid levels | GCST90200252 | 1.55 |
| 5195 | Oily fish consumption | GCST90132993 | 1.55 |
| 5196 | UXS1 levels | GCST90471023 | 1.55 |
| 5197 | Bone marrow fat fraction of right proximal femur | GCST90652393 | 1.55 |
| 5198 | Non-ischemic cardiomyopathy | FING00000873 | 1.54 |
| 5199 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320900 | 1.54 |
| 5200 | CCL25/PRSS27 ratio | GCST90313694 | 1.54 |
| 5201 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T314 | ECGU000314 | 1.54 |
| 5202 | Takes medication for peripheral vascular disease? | GCST90475220 | 1.54 |
| 5203 | CXCL12/TIMP3 ratio | GCST90314338 | 1.54 |
| 5204 | Polycystic ovarian syndrome, consortium definition | FING00001184 | 1.54 |
| 5205 | TNFRSF11B/TNFSF11 ratio | GCST90315930 | 1.54 |
| 5206 | ITGB1BP2/USP8 ratio | GCST90315223 | 1.54 |
| 5207 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T421 | ECGA000421 | 1.54 |
| 5208 | GATD3 levels | GCST90469309 | 1.54 |
| 5209 | NRP1 levels | GCST90470085 | 1.54 |
| 5210 | C1QTNF1/COL18A1 ratio | GCST90313551 | 1.54 |
| 5211 | F-savour/caloric food liking (derived food-liking factor) | GCST90094835 | 1.53 |
| 5212 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T456 | ECGA000456 | 1.53 |
| 5213 | Saturated fatty acids to total fatty acids percentage | GCST90502701 | 1.53 |
| 5214 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 1.53 |
| 5215 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007526 | 1.53 |
| 5216 | PARP1 levels | GCST90470160 | 1.53 |
| 5217 | Triacylglycerol_53:4_[M+NH4]1+ levels | GCST90060524 | 1.53 |
| 5218 | RPE levels | GCST90470495 | 1.52 |
| 5219 | Parental longevity (mother's attained age) | GCST006696 | 1.52 |
| 5220 | SCARF1 levels | GCST90470536 | 1.52 |
| 5221 | HRG levels | GCST90469476 | 1.52 |
| 5222 | Total lipid levels in very small VLDL | GCST90093034 | 1.52 |
| 5223 | CXCL5/MESD ratio | GCST90314350 | 1.52 |
| 5224 | PALM levels | GCST90470154 | 1.52 |
| 5225 | Autoimmune hyperthyroidism | FING00000134 | 1.52 |
| 5226 | Total Dihexosylceramide levels | GCST90025193 | 1.52 |
| 5227 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476357 | 1.52 |
| 5228 | SLC27A4/TDRKH ratio | GCST90315851 | 1.52 |
| 5229 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T313 | ECGA000313 | 1.52 |
| 5230 | IL18BP/ROR1 ratio | GCST90315155 | 1.52 |
| 5231 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T292 | ECGA000292 | 1.52 |
| 5232 | IDP dMRI ProbtrackX FA ar r | GCST90003926 | 1.52 |
| 5233 | Total Sphingomyelin levels | GCST90025842 | 1.52 |
| 5234 | DTI TBSS L3 Anterior limb of internal capsule R | GCST90384540 | 1.52 |
| 5235 | PDGFC levels | GCST90470190 | 1.51 |
| 5236 | FAM3D levels | GCST90469188 | 1.51 |
| 5237 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T292 | ECGU000292 | 1.51 |
| 5238 | Hair colour (natural, before greying): Dark brown (UKB data field 1747_4) | GCST90041839 | 1.51 |
| 5239 | NGRN levels | GCST90470045 | 1.51 |
| 5240 | X-13548 levels | GCST90243821 | 1.51 |
| 5241 | Total testosterone levels | GCST90012114 | 1.51 |
| 5242 | Microscopic polyangiitis | FING00000817 | 1.51 |
| 5243 | DTI TBSS MD Posterior limb of internal capsule L | GCST90384591 | 1.51 |
| 5244 | Poisoning by antibiotics | injuries & poisonings | UKBB00000653 | 1.51 |
| 5245 | SCAMP3 levels | GCST90470532 | 1.51 |
| 5246 | CD84/F2R ratio | GCST90313912 | 1.51 |
| 5247 | TBC1D23 levels | GCST90470810 | 1.51 |
| 5248 | IDP dMRI TBSS OD Body of corpus callosum | GCST90004405 | 1.50 |
| 5249 | CD69/CHMP1A ratio | GCST90313868 | 1.50 |
| 5250 | RGS10 levels | GCST90470465 | 1.50 |
| 5251 | IDP dMRI ProbtrackX L3 cgc r | GCST90004305 | 1.50 |
| 5252 | BST2/MME ratio | GCST90313539 | 1.50 |
| 5253 | RNF43 levels | GCST90422482 | 1.50 |
| 5254 | HMBS/UBAC1 ratio | GCST90315066 | 1.50 |
| 5255 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T395 | ECGA000395 | 1.50 |
| 5256 | Age spots | GCST006096 | 1.50 |
| 5257 | SULT1A1 levels | GCST90470781 | 1.50 |
| 5258 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T96 | ECGA000096 | 1.50 |
| 5259 | SRC/TBL1X ratio | GCST90315884 | 1.50 |
| 5260 | MATN2 levels | GCST90469864 | 1.50 |
| 5261 | Qualifications - CSEs or equivalent | Education | UKBB00000728 | 1.50 |
| 5262 | IL22RA2 levels | GCST90090699 | 1.49 |
| 5263 | CA11 levels | GCST90468506 | 1.49 |
| 5264 | IDP T2 FLAIR BIANCA WMH volume | GCST90003862 | 1.49 |
| 5265 | IL7 levels | GCST90469606 | 1.49 |
| 5266 | IDP dMRI TBSS MD Retrolenticular part of internal capsule R | GCST90004047 | 1.49 |
| 5267 | Plasma 2-aminobutyrate levels in chronic kidney disease | GCST90264339 | 1.49 |
| 5268 | Concentration of small LDL particles (UKB data field 23544) | GCST90269641 | 1.49 |
| 5269 | Phospholipids to total lipids in very large VLDL percentage (UKB data field 23584) | GCST90269681 | 1.49 |
| 5270 | Cooked vegetables consumption | GCST90132977 | 1.49 |
| 5271 | Moderate to vigorous physical activity duration | GCST90061422 | 1.49 |
| 5272 | TNFRSF1B levels | GCST90012026 | 1.49 |
| 5273 | Spread type: Butter vs never use spread (UKB data field 1428) | GCST90132952 | 1.49 |
| 5274 | DECR1/FXN ratio | GCST90314446 | 1.49 |
| 5275 | HBEGF/WWP2 ratio | GCST90315038 | 1.49 |
| 5276 | Infections of the skin and subcutaneous tissue | FING00000670 | 1.48 |
| 5277 | PPP1R2/USP8 ratio | GCST90315723 | 1.48 |
| 5278 | Hippocampal left GC-ML-DG volume (head) | GCST90267946 | 1.48 |
| 5279 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T322 | ECGA000322 | 1.48 |
| 5280 | CPXM2 levels | GCST90468850 | 1.48 |
| 5281 | WNT9A levels | GCST90471079 | 1.48 |
| 5282 | TGOLN2 levels | GCST90470850 | 1.48 |
| 5283 | CEP20 levels | GCST90468712 | 1.48 |
| 5284 | CASP8/PPP3R1 ratio | GCST90313654 | 1.48 |
| 5285 | Reticulocyte fraction of red cells | GCST004619 | 1.48 |
| 5286 | X-12749 levels | GCST90243770 | 1.48 |
| 5287 | DSC2 levels | GCST90469040 | 1.47 |
| 5288 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98 | ECGA000098 | 1.47 |
| 5289 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359 | ECGA000359 | 1.47 |
| 5290 | VGF levels | GCST90471038 | 1.47 |
| 5291 | 1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels | GCST90200046 | 1.47 |
| 5292 | PTH1R levels | GCST90470371 | 1.47 |
| 5293 | Non-cancer illness code, self-reported - hiatus hernia | Medical conditions | UKBB00000515 | 1.47 |
| 5294 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T454 | ECGA000454 | 1.47 |
| 5295 | IDP dMRI TBSS FA Fornix | GCST90003882 | 1.47 |
| 5296 | Sleep disorders (combined) | FING00001311 | 1.47 |
| 5297 | CR2 levels | GCST90468852 | 1.47 |
| 5298 | Urine N-acetyl-cadaverine levels in chronic kidney disease | GCST90265541 | 1.47 |
| 5299 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360 | ECGA000360 | 1.47 |
| 5300 | Risk taking (standard GWA) | GCST90267298 | 1.46 |
| 5301 | CSF1/IFNGR1 ratio | GCST90314283 | 1.46 |
| 5302 | IDP dMRI ProbtrackX L1 ilf l | GCST90004260 | 1.46 |
| 5303 | PLXNA4/SUSD1 ratio | GCST90315689 | 1.46 |
| 5304 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T77 | ECGU000077 | 1.46 |
| 5305 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T104 | ECGA000104 | 1.46 |
| 5306 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T369 | ECGU000369 | 1.46 |
| 5307 | GALNT10/SEMA7A ratio | GCST90314915 | 1.46 |
| 5308 | Right-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302774 | 1.46 |
| 5309 | PPP1R12A levels | GCST90470300 | 1.46 |
| 5310 | IDP dMRI ProbtrackX L3 cst r | GCST90004309 | 1.46 |
| 5311 | Crohn's disease | GCST90475318 | 1.46 |
| 5312 | Processed meat consumption | GCST90132995 | 1.46 |
| 5313 | Triacylglycerol_56:6_[M+NH4]1+ levels | GCST90060553 | 1.46 |
| 5314 | FCRL1/TREML2 ratio | GCST90314797 | 1.46 |
| 5315 | Bariatric surgery (PheCode 539) | GCST90476055 | 1.45 |
| 5316 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502580 | 1.45 |
| 5317 | T1 FreeSurfer a2009s rh S calcarine area | GCST90384933 | 1.45 |
| 5318 | F7/F9 ratio | GCST90314743 | 1.45 |
| 5319 | Blood cell traits latent factor 10 (platelet) | GCST90559252 | 1.45 |
| 5320 | Childhood body mass index | GCST90002409 | 1.45 |
| 5321 | rfMRI amplitudes (ICA100 node 7) | GCST90004595 | 1.45 |
| 5322 | wg lh intensity-contrast parahippocampal | GCST90003807 | 1.45 |
| 5323 | Takes medication for Macular Degeneration? | GCST90475387 | 1.45 |
| 5324 | wg rh intensity-contrast lateraloccipital | GCST90003837 | 1.45 |
| 5325 | ZBTB16 levels | GCST90471095 | 1.45 |
| 5326 | HSDL2 levels | GCST90469485 | 1.44 |
| 5327 | ISEI occupational score | GCST90446160 | 1.44 |
| 5328 | Unstable angina (intermediate coronary syndrome) | circulatory system | UKBB00000883 | 1.44 |
| 5329 | CD5 levels | GCST90274773 | 1.44 |
| 5330 | CRNN levels | GCST90468869 | 1.44 |
| 5331 | Visceral adipose tissue volume | GCST90016671 | 1.44 |
| 5332 | FRZB levels | GCST90469269 | 1.44 |
| 5333 | Varicose veins of lower extremity (PheCode 454.1) | GCST90476013 | 1.44 |
| 5334 | AmygNuclei lh volume Medial-nucleus | GCST90002653 | 1.44 |
| 5335 | Coeliac disease | GCST90468120 | 1.44 |
| 5336 | Birth size (multivariate analysis) | GCST90624101 | 1.44 |
| 5337 | GALNT5 levels | GCST90469298 | 1.43 |
| 5338 | PFKM levels | GCST90618802 | 1.43 |
| 5339 | SNAP23/SNAP29 ratio | GCST90315855 | 1.43 |
| 5340 | ALCAM/ICAM3 ratio | GCST90313237 | 1.43 |
| 5341 | Hearing (confirmatory factor analysis Factor 32) | GCST90309366 | 1.43 |
| 5342 | Polyglandular dysfunction | FING00001186 | 1.43 |
| 5343 | PPME1 levels | GCST90470298 | 1.43 |
| 5344 | BTC levels | GCST90468476 | 1.43 |
| 5345 | PTPRF levels | GCST90470381 | 1.43 |
| 5346 | Mean corpuscular volume | GCST90018746 | 1.43 |
| 5347 | AmygNuclei rh volume Basal-nucleus | GCST90002659 | 1.42 |
| 5348 | Open bite | FING00000903 | 1.42 |
| 5349 | Thyroid stimulating hormone levels within normal range in pregnancy | GCST90435195 | 1.42 |
| 5350 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T316 | ECGU000316 | 1.42 |
| 5351 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 1.42 |
| 5352 | Fasting plasma glucose | GCST90297787 | 1.42 |
| 5353 | SELP levels | GCST90470569 | 1.42 |
| 5354 | DBNL/EDAR ratio | GCST90314416 | 1.42 |
| 5355 | Behenoyl dihydrosphingomyelin (d18:0/22:0) levels | GCST90200059 | 1.42 |
| 5356 | SFTPA1 levels | GCST90470612 | 1.42 |
| 5357 | Triacylglycerol (50:0) [NL-18:0] levels | GCST90025151 | 1.42 |
| 5358 | Anorexia (incl.atypical) | FING00000093 | 1.42 |
| 5359 | REST UKBBICA NODEamps25 0005 | GCST90385488 | 1.41 |
| 5360 | Phosphatidylcholine-O_36:4_[M+H]1+/Phosphatidylcholine-P_36:3_[M+H]1+ levels | GCST90060318 | 1.41 |
| 5361 | EGLN1/PSIP1 ratio | GCST90314620 | 1.41 |
| 5362 | F-fatty food liking (derived food-liking factor) | GCST90094761 | 1.41 |
| 5363 | PDGFB/UXS1 ratio | GCST90315634 | 1.41 |
| 5364 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 1.41 |
| 5365 | Irritable bowel syndrome | GCST90016564 | 1.41 |
| 5366 | BANK1 levels | GCST90468421 | 1.41 |
| 5367 | Feeling hurt | GCST006951 | 1.41 |
| 5368 | Goat cheese liking | GCST90094773 | 1.41 |
| 5369 | aparc-a2009s lh volume S-precentral-sup-part | GCST90002993 | 1.41 |
| 5370 | SORD levels | GCST90470709 | 1.41 |
| 5371 | Free cholesterol to total lipids in large VLDL percentage (UKB data field 23592) | GCST90269689 | 1.41 |
| 5372 | PTN levels | GCST90470374 | 1.41 |
| 5373 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T314 | ECGA000314 | 1.41 |
| 5374 | Diseases of sebaceous glands (PheCode 706) | GCST90476210 | 1.41 |
| 5375 | Right-hemisphere visual network to hippocampus white-matter structural connectivity | GCST90302785 | 1.40 |
| 5376 | IL19 levels | GCST90469568 | 1.40 |
| 5377 | GPI levels | GCST90241269 | 1.40 |
| 5378 | GNLY levels | GCST90469372 | 1.40 |
| 5379 | ATP5IF1/FXN ratio | GCST90313386 | 1.40 |
| 5380 | Left molecular layer hippocampal volume (body) | GCST90267953 | 1.40 |
| 5381 | INPPL1 levels | GCST90469619 | 1.40 |
| 5382 | Completion of the aide-memoire | GCST90012793 | 1.40 |
| 5383 | Eosinophil count | GCST90002299 | 1.40 |
| 5384 | Total lipids in small LDL (UKB data field 23545) | GCST90269642 | 1.40 |
| 5385 | GLT25D1 levels | GCST90426421 | 1.40 |
| 5386 | MIF levels | GCST90089018 | 1.39 |
| 5387 | DNAJB1/EIF4B ratio | GCST90314508 | 1.39 |
| 5388 | FOXO1/IRAK4 ratio | GCST90314870 | 1.39 |
| 5389 | Phospholipids to Total Lipids in Small VLDL percentage | GCST90499895 | 1.39 |
| 5390 | DNA methylation GrimAge acceleration | GCST90014288 | 1.39 |
| 5391 | aseg lh volume Pallidum | GCST90002623 | 1.39 |
| 5392 | IDP dMRI ProbtrackX L3 slf r | GCST90004322 | 1.39 |
| 5393 | IDP dMRI TBSS FA External capsule R | GCST90003909 | 1.39 |
| 5394 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T347 | ECGA000347 | 1.39 |
| 5395 | aparc-pial lh area caudalmiddlefrontal | GCST90003144 | 1.39 |
| 5396 | POMC levels | GCST90470284 | 1.39 |
| 5397 | Cereal consumption (bowls per week) (UKB data field 1458) | GCST90132982 | 1.39 |
| 5398 | DAB2/FKBP1B ratio | GCST90314362 | 1.39 |
| 5399 | MBL2 levels | GCST90469868 | 1.39 |
| 5400 | NAAA levels | GCST90469991 | 1.39 |
| 5401 | CIAPIN1/SNX9 ratio | GCST90314068 | 1.39 |
| 5402 | IDP dMRI TBSS FA Posterior limb of internal capsule L | GCST90003896 | 1.38 |
| 5403 | GRP levels | GCST90469406 | 1.38 |
| 5404 | eosinophil (absolute count, mean, inv-norm transformed) | GCST90475291 | 1.38 |
| 5405 | Ectropion or entropion (PheCode 374.1) | GCST90475891 | 1.38 |
| 5406 | Eosinophill count (UKB data field 30150) | GCST90468068 | 1.38 |
| 5407 | PTPRF/SDC1 ratio | GCST90315752 | 1.38 |
| 5408 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T420 | ECGA000420 | 1.38 |
| 5409 | IDP dMRI ProbtrackX L3 cgc l | GCST90004304 | 1.38 |
| 5410 | APP/EGF ratio | GCST90313322 | 1.38 |
| 5411 | Severity of induration at injection site at the injection site after COVID-19 booster vaccination | GCST90454409 | 1.38 |
| 5412 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T302 | ECGA000302 | 1.38 |
| 5413 | Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organs | UKBB00000425 | 1.38 |
| 5414 | T1 FIRST volume BrStem | GCST90383989 | 1.38 |
| 5415 | Biological Father: Chronic Lung Disease including COPD, Emphysema or Bronchitis | GCST90475247 | 1.38 |
| 5416 | wg rh intensity-contrast bankssts | GCST90003828 | 1.38 |
| 5417 | T1 FreeSurfer DK rh pericalcarine area | GCST90385709 | 1.38 |
| 5418 | BCAM/PCDH17 ratio | GCST90313475 | 1.38 |
| 5419 | Alcohol frequency weekly (weighted GWA) | GCST90267267 | 1.38 |
| 5420 | SMPD1 levels | GCST90470684 | 1.38 |
| 5421 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 1.38 |
| 5422 | OPLAH levels | GCST90470127 | 1.37 |
| 5423 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T147 | ECGU000147 | 1.37 |
| 5424 | DTI TBSS L2 Genu of corpus callosum | GCST90384478 | 1.37 |
| 5425 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 1.37 |
| 5426 | Medication for pain relief, constipation, heartburn - Aspirin | Medication | UKBB00000454 | 1.37 |
| 5427 | Coffee consumption (cups per day) | GCST90132984 | 1.37 |
| 5428 | Diacylglycerol_42:7_[M+H-H2O]1+ levels | GCST90060226 | 1.37 |
| 5429 | SNX9 levels | GCST90470703 | 1.37 |
| 5430 | PADI2 levels | GCST90470142 | 1.37 |
| 5431 | SDCCAG8 levels | GCST90470560 | 1.37 |
| 5432 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5) | GCST90320568 | 1.37 |
| 5433 | Light smokers, at least 100 smokes in lifetime | Smoking | UKBB00000407 | 1.37 |
| 5434 | aparc-Desikan rh volume supramarginal | GCST90002831 | 1.36 |
| 5435 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T224 | ECGU000224 | 1.36 |
| 5436 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T140 | ECGU000140 | 1.36 |
| 5437 | CD48/CRTAM ratio | GCST90313839 | 1.36 |
| 5438 | wg rh intensity-contrast frontalpole | GCST90003858 | 1.36 |
| 5439 | Phosphatidylcholine_34:0_[M+H]1+/Phosphatidylethanolamine_37:0_[M+H]1+/Phosphatidate_39:1_[M+NH4]1+ levels | GCST90060311 | 1.36 |
| 5440 | APP/CD40LG ratio | GCST90313319 | 1.36 |
| 5441 | T1 CAT volume L LeftPutamen | GCST90384100 | 1.36 |
| 5442 | X-13435 levels | GCST90243811 | 1.36 |
| 5443 | Nephrotic syndrome | GCST90018664 | 1.36 |
| 5444 | Volume of right whole amygdala | GCST90475054 | 1.36 |
| 5445 | C3 levels | GCST90468498 | 1.36 |
| 5446 | SNX9/VASH1 ratio | GCST90315866 | 1.35 |
| 5447 | Cod liking | GCST90094736 | 1.35 |
| 5448 | GALNT3 levels | GCST90469297 | 1.35 |
| 5449 | Other menopausal disorders | FING00001071 | 1.35 |
| 5450 | DKK4/REG1B ratio | GCST90314490 | 1.35 |
| 5451 | SNAP29/VEGFC ratio | GCST90315862 | 1.35 |
| 5452 | Glycine levels | GCST90497315 | 1.35 |
| 5453 | wg lh intensity-contrast middletemporal | GCST90003806 | 1.35 |
| 5454 | Cholesteryl ester_14:0_[M+NH4]1+ levels | GCST90060197 | 1.35 |
| 5455 | SPINK2 levels | GCST90470722 | 1.35 |
| 5456 | High cholesterol | GCST90475203 | 1.35 |
| 5457 | EDAR/TACC3 ratio | GCST90314589 | 1.34 |
| 5458 | aparc-DKTatlas rh area superiorparietal | GCST90003292 | 1.34 |
| 5459 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108 | ECGU000108 | 1.34 |
| 5460 | AAGAB levels | GCST90617473 | 1.34 |
| 5461 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T99 | ECGU000099 | 1.34 |
| 5462 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T419 | ECGA000419 | 1.34 |
| 5463 | F-cooking flavour liking (derived food-liking factor) | GCST90094742 | 1.34 |
| 5464 | Phosphatidylcholine_34:1_[M+H]1+/Phosphatidylethanolamine_37:1_[M+H]1+/Phosphatidate_39:2_[M+NH4]1+ levels | GCST90060307 | 1.34 |
| 5465 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T396 | ECGA000396 | 1.34 |
| 5466 | S100A4/SNAP29 ratio | GCST90315801 | 1.34 |
| 5467 | Triglycerides to total lipids in small LDL percentage (UKB data field 23628) | GCST90269725 | 1.34 |
| 5468 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T58 | ECGA000058 | 1.34 |
| 5469 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368 | ECGU000368 | 1.34 |
| 5470 | CTF1/ITGB1BP2 ratio | GCST90314305 | 1.33 |
| 5471 | ICA1/TANK ratio | GCST90315112 | 1.33 |
| 5472 | IDP dMRI TBSS MD Anterior corona radiata R | GCST90004049 | 1.33 |
| 5473 | Croissant liking | GCST90094748 | 1.33 |
| 5474 | A4GALT levels | GCST90427457 | 1.33 |
| 5475 | PRTN3 levels | GCST90470348 | 1.33 |
| 5476 | Cancer | GCST90086052 | 1.33 |
| 5477 | Intrahepatic Cholestasis of Pregnancy (ICP)  (more control exclusions) | FING00000692 | 1.33 |
| 5478 | NAGPA levels | GCST90469996 | 1.33 |
| 5479 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T132 | ECGU000132 | 1.33 |
| 5480 | BCR/ICA1 ratio | GCST90313493 | 1.33 |
| 5481 | Free cholesterol levels in very small VLDL | GCST90093032 | 1.33 |
| 5482 | Lysoalkenylphosphatidylethanolamine (P-20:0) levels | GCST90025460 | 1.33 |
| 5483 | Platelet count during second trimester of pregnancy | GCST90302225 | 1.33 |
| 5484 | ROR1/THBD ratio | GCST90315786 | 1.33 |
| 5485 | CD59/CST6 ratio | GCST90313857 | 1.33 |
| 5486 | Thyrotoxicosis with or without goiter (PheCode 242) | GCST90475643 | 1.33 |
| 5487 | DTI autoptx FA unc r tract | GCST90385138 | 1.32 |
| 5488 | PRND levels | GCST90470333 | 1.32 |
| 5489 | DTI autoptx MD cgc r tract | GCST90385225 | 1.32 |
| 5490 | Atrial fibrillation and flutter | circulatory system | UKBB00000055 | 1.32 |
| 5491 | CALB1 levels | GCST90468526 | 1.32 |
| 5492 | Ever felt worried, tense, or anxious for most of a month or longer | Anxiety | UKBB00000215 | 1.32 |
| 5493 | Platelet count | GCST90278640 | 1.32 |
| 5494 | Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivity | GCST90302810 | 1.32 |
| 5495 | PILRA/TNFRSF1A ratio | GCST90315655 | 1.32 |
| 5496 | Total cholesterol levels | GCST90500022 | 1.32 |
| 5497 | TNFSF12 levels | GCST90274846 | 1.32 |
| 5498 | COMT levels | GCST90468828 | 1.32 |
| 5499 | Body fat percentage | GCST90103752 | 1.32 |
| 5500 | GZMB levels | GCST90469424 | 1.32 |
| 5501 | Hair colour (natural, before greying) - Dark brown | Sun exposure | UKBB00000297 | 1.32 |
| 5502 | IDP dMRI TBSS L3 Superior longitudinal fasciculus R | GCST90004211 | 1.32 |
| 5503 | TARBP2 levels | GCST90470805 | 1.32 |
| 5504 | FGFR2 levels | GCST90469233 | 1.32 |
| 5505 | RRM2B/SMAD1 ratio | GCST90315788 | 1.31 |
| 5506 | rfMRI amplitudes (ICA25 node 14) | GCST90004581 | 1.31 |
| 5507 | Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels | GCST90060395 | 1.31 |
| 5508 | Bell's palsy | FING00000144 | 1.31 |
| 5509 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 1.31 |
| 5510 | aparc-pial rh area superiorparietal | GCST90003202 | 1.31 |
| 5511 | IDP dMRI ProbtrackX L1 slf r | GCST90004268 | 1.31 |
| 5512 | MGAT2 levels | GCST90089560 | 1.31 |
| 5513 | Regional enteritis (PheCode 555.1) | GCST90476066 | 1.31 |
| 5514 | T1 FreeSurfer DKT rh pericalcarine area | GCST90384305 | 1.31 |
| 5515 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T312 | ECGA000312 | 1.31 |
| 5516 | IDP dMRI ProbtrackX MD slf r | GCST90004241 | 1.31 |
| 5517 | Rheumatoid arthritis (PheCode 714.1) | GCST90476230 | 1.30 |
| 5518 | Glomerular diseases | FING00000581 | 1.30 |
| 5519 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367 | ECGU000367 | 1.30 |
| 5520 | Frequency of walking for pleasure in last 4 weeks | Physical activity | UKBB00000271 | 1.30 |
| 5521 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 1.30 |
| 5522 | Occupational attainment | GCST90102253 | 1.30 |
| 5523 | HBEGF levels | GCST90241392 | 1.30 |
| 5524 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 1.30 |
| 5525 | CD74/TNFRSF21 ratio | GCST90313897 | 1.30 |
| 5526 | T1 FreeSurfer DK rh cuneus area | GCST90385693 | 1.30 |
| 5527 | DPEP1 levels | GCST90469030 | 1.30 |
| 5528 | wg lh intensity-contrast pericalcarine | GCST90003812 | 1.30 |
| 5529 | Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41) | GCST90668485 | 1.30 |
| 5530 | SERPINB1/SERPINB6 ratio | GCST90315826 | 1.30 |
| 5531 | IDP T1 FAST ROIs R cerebellum VIIb | GCST90002577 | 1.30 |
| 5532 | Methods of admission to hospital (recoded) - Elective admission: Booked | Summary Administration | UKBB00000461 | 1.30 |
| 5533 | CD79B/CKAP4 ratio | GCST90313898 | 1.30 |
| 5534 | HSPB1 levels | GCST90469489 | 1.30 |
| 5535 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T418 | ECGA000418 | 1.29 |
| 5536 | T1 FreeSurfer BA rh BA3b exvivo area | GCST90385550 | 1.29 |
| 5537 | 3-hydroxybutyrate levels (UKB data field 23474) | GCST90269571 | 1.29 |
| 5538 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358 | ECGA000358 | 1.29 |
| 5539 | Hereditary and idiopathic peripheral neuropathy (PheCode 356) | GCST90475844 | 1.29 |
| 5540 | Phosphatidylcholine_34:4_[M+H]1+/Phosphatidylethanolamine_37:4_[M+H]1+/Phosphatidate_39:5_[M+NH4]1+ levels | GCST90060295 | 1.29 |
| 5541 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T296 | ECGA000296 | 1.29 |
| 5542 | GP6/HPCAL1 ratio | GCST90314963 | 1.29 |
| 5543 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476363 | 1.29 |
| 5544 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 1.29 |
| 5545 | FURIN/INHBC ratio | GCST90314886 | 1.29 |
| 5546 | Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heel | UKBB00000321 | 1.29 |
| 5547 | Insomnia complaints | GCST006488 | 1.28 |
| 5548 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 1.28 |
| 5549 | CD40LG levels | GCST90468632 | 1.28 |
| 5550 | Incisional hernia (PheCode 550.6) | GCST90476064 | 1.28 |
| 5551 | IDP T1 FAST ROIs R cerebellum VIIIb | GCST90002583 | 1.28 |
| 5552 | TIMP4 levels | GCST90470872 | 1.28 |
| 5553 | Lymphoid neoplasms (somatic mutation group 2 phenocluster) | GCST90624750 | 1.28 |
| 5554 | MED18/SH2B3 ratio | GCST90315412 | 1.28 |
| 5555 | Blood cell traits latent factor 3 (white cell) | GCST90559245 | 1.28 |
| 5556 | CD48 levels | GCST90468635 | 1.28 |
| 5557 | PM: initial answer - Blue square | Prospective memory | UKBB00000651 | 1.28 |
| 5558 | Noninflammatory disorders of female genital tract | FING00000882 | 1.28 |
| 5559 | Brain age gap | GCST90558034 | 1.28 |
| 5560 | NELL1 levels | GCST90242481 | 1.27 |
| 5561 | Creatinine (enzymatic) in urine | Urine assays | UKBB00000155 | 1.27 |
| 5562 | FABP4 levels | GCST90012075 | 1.27 |
| 5563 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T227 | ECGA000227 | 1.27 |
| 5564 | ARHGAP1 levels | GCST90468352 | 1.27 |
| 5565 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502592 | 1.27 |
| 5566 | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) metabolite level | GCST90616405 | 1.27 |
| 5567 | Bitter ale liking | GCST90094705 | 1.27 |
| 5568 | ENG/NOTCH1 ratio | GCST90314648 | 1.27 |
| 5569 | NQO2 levels | GCST90242679 | 1.27 |
| 5570 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283 | ECGU000283 | 1.27 |
| 5571 | Concentration of medium VLDL particles | GCST90499017 | 1.26 |
| 5572 | CRACR2A/LBR ratio | GCST90314228 | 1.26 |
| 5573 | T1 FreeSurfer a2009s rh S temporal sup area | GCST90384962 | 1.26 |
| 5574 | Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia | GCST90624744 | 1.26 |
| 5575 | KLRF1 levels | GCST90469712 | 1.26 |
| 5576 | Coffee intake (standard GWA) | GCST90267274 | 1.26 |
| 5577 | HEPACAM2 levels | GCST90469445 | 1.26 |
| 5578 | CCN2/VEGFC ratio | GCST90313719 | 1.26 |
| 5579 | IDP dMRI TBSS FA Superior cerebellar peduncle R | GCST90003889 | 1.26 |
| 5580 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88 | ECGA000088 | 1.26 |
| 5581 | ERBIN levels | GCST90469142 | 1.26 |
| 5582 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T311 | ECGU000311 | 1.26 |
| 5583 | aparc-Desikan lh area caudalmiddlefrontal | GCST90003076 | 1.26 |
| 5584 | High light scatter reticulocyte count | Blood count | UKBB00000326 | 1.26 |
| 5585 | Spondylolisthesis/Spondylolysis | FING00001324 | 1.26 |
| 5586 | ZBTB17 levels | GCST90471096 | 1.26 |
| 5587 | F-savoury food liking (derived food-liking factor) | GCST90094833 | 1.26 |
| 5588 | PRR4 levels | GCST90470338 | 1.26 |
| 5589 | DTI TBSS L3 Posterior corona radiata L | GCST90384551 | 1.25 |
| 5590 | DFFA/SIRT2 ratio | GCST90314462 | 1.25 |
| 5591 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T415 | ECGA000415 | 1.25 |
| 5592 | PON2 levels | GCST90470286 | 1.25 |
| 5593 | Cholesteryl esters to total lipids in small VLDL percentage (UKB data field 23601) | GCST90269698 | 1.25 |
| 5594 | Total cholesterol response to statins (relative logarithmic difference) | GCST90455608 | 1.25 |
| 5595 | SORT1/ST6GAL1 ratio | GCST90315869 | 1.25 |
| 5596 | BA-exvivo rh area BA4a | GCST90003225 | 1.25 |
| 5597 | TST levels | GCST90470982 | 1.25 |
| 5598 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366 | ECGU000366 | 1.25 |
| 5599 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 66) | GCST90320629 | 1.25 |
| 5600 | Fibromuscular dysplasia | GCST90026612 | 1.25 |
| 5601 | Hereditary deficiency of other clotting factors | FING00000612 | 1.24 |
| 5602 | IDP dMRI TBSS FA Anterior corona radiata L | GCST90003900 | 1.24 |
| 5603 | Red blood cell count | GCST90018751 | 1.24 |
| 5604 | CLEC4D/TGFA ratio | GCST90314117 | 1.24 |
| 5605 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T350 | ECGA000350 | 1.24 |
| 5606 | IDP dMRI TBSS ICVF Superior cerebellar peduncle L | GCST90004340 | 1.24 |
| 5607 | FUT8 levels | GCST90469281 | 1.24 |
| 5608 | SPRY2 levels | GCST90470738 | 1.24 |
| 5609 | Cholesteryl ester_18:2_[M+NH4]1+ levels | GCST90060220 | 1.24 |
| 5610 | Triacylglycerol_51:3_[M+NH4]1+ levels | GCST90060494 | 1.24 |
| 5611 | Number of attempts | Prospective memory | UKBB00000531 | 1.24 |
| 5612 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T416 | ECGA000416 | 1.24 |
| 5613 | GLB1/GUSB ratio | GCST90314931 | 1.24 |
| 5614 | DBNL levels | GCST90468951 | 1.24 |
| 5615 | MIA/NBL1 ratio | GCST90315445 | 1.24 |
| 5616 | BCAM/ICAM4 ratio | GCST90313472 | 1.24 |
| 5617 | CKAP4/IL4R ratio | GCST90314072 | 1.23 |
| 5618 | MAP3K5/MAVS ratio | GCST90315379 | 1.23 |
| 5619 | ERBIN/TBC1D23 ratio | GCST90314698 | 1.23 |
| 5620 | SH2D1A levels | GCST90470617 | 1.23 |
| 5621 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117 | ECGA000117 | 1.23 |
| 5622 | NECTIN4/TGFBR2 ratio | GCST90315535 | 1.23 |
| 5623 | TRIM24 levels | GCST90470965 | 1.23 |
| 5624 | Atrial fibrillation and flutter | Other forms of heart disease | UKBB00000056 | 1.23 |
| 5625 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T352 | ECGA000352 | 1.23 |
| 5626 | Comfortable retirement (confirmatory factor analysis Factor 29) | GCST90309363 | 1.23 |
| 5627 | FXN levels | GCST90469282 | 1.23 |
| 5628 | IDP T1 FAST ROIs L hippocampus | GCST90002555 | 1.22 |
| 5629 | High cholesterol | GCST90468134 | 1.22 |
| 5630 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T417 | ECGA000417 | 1.22 |
| 5631 | CLC/RNASE3 ratio | GCST90314077 | 1.22 |
| 5632 | Right-hemisphere salience/ventral attention network to putamen white-matter structural connectivity | GCST90302819 | 1.22 |
| 5633 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T273 | ECGU000273 | 1.22 |
| 5634 | IDP dMRI ProbtrackX ISOVF slf l | GCST90004546 | 1.22 |
| 5635 | Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00000777 | 1.22 |
| 5636 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T274 | ECGU000274 | 1.22 |
| 5637 | LGALS8 levels | GCST90469764 | 1.22 |
| 5638 | SERPINF1 levels | GCST90470598 | 1.22 |
| 5639 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T281 | ECGU000281 | 1.22 |
| 5640 | Tyrosine levels | GCST90500143 | 1.22 |
| 5641 | CALCOCO2 levels | GCST90468531 | 1.21 |
| 5642 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T116 | ECGA000116 | 1.21 |
| 5643 | Acute renal failure | FING00000030 | 1.21 |
| 5644 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 1.21 |
| 5645 | PPT1 levels | GCST90427718 | 1.21 |
| 5646 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T329 | ECGU000329 | 1.21 |
| 5647 | SCARF1/SUSD1 ratio | GCST90315811 | 1.21 |
| 5648 | DNAJB14 levels | GCST90427235 | 1.21 |
| 5649 | Pilonidal cyst | FING00001167 | 1.21 |
| 5650 | FLT3/FLT3LG ratio | GCST90314859 | 1.21 |
| 5651 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T67 | ECGA000067 | 1.21 |
| 5652 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T349 | ECGA000349 | 1.21 |
| 5653 | SDC4 levels | GCST90470559 | 1.21 |
| 5654 | BCR/VASH1 ratio | GCST90313499 | 1.21 |
| 5655 | CD58 levels | GCST90468638 | 1.21 |
| 5656 | eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment) | GCST90624778 | 1.20 |
| 5657 | Prospective memory result | Prospective memory | UKBB00000713 | 1.20 |
| 5658 | FCRL2/LY9 ratio | GCST90314799 | 1.20 |
| 5659 | Coffee type - Decaffeinated coffee (any type) | Diet | UKBB00000139 | 1.20 |
| 5660 | CCL5/SELP ratio | GCST90313705 | 1.20 |
| 5661 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T30 | ECGU000030 | 1.20 |
| 5662 | Moderate-to-vigorous intensity physical activity during leisure time | GCST90104341 | 1.20 |
| 5663 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 1.20 |
| 5664 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90024197 | 1.20 |
| 5665 | EIF4G1/FKBP5 ratio | GCST90314633 | 1.20 |
| 5666 | LY96/ST6GAL1 ratio | GCST90315348 | 1.20 |
| 5667 | IDP dMRI TBSS ICVF Pontine crossing tract | GCST90004328 | 1.19 |
| 5668 | Left hippocampal volume (tail) | GCST90267951 | 1.19 |
| 5669 | Cholesterol levels in medium LDL | GCST90092904 | 1.19 |
| 5670 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T115 | ECGA000115 | 1.19 |
| 5671 | Paroxysmal supraventricular tachycardia (PheCode 427.11) | GCST90475964 | 1.19 |
| 5672 | Principal component-derived dietary pattern 43 | GCST90133048 | 1.19 |
| 5673 | Parental longevity (combined parental age at death) | GCST006702 | 1.19 |
| 5674 | Main speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000417 | 1.19 |
| 5675 | Disorders of eyelid, lacrimal system and orbit | FING00000439 | 1.19 |
| 5676 | Weight, inverse-rank normalized | FING00001447 | 1.19 |
| 5677 | Left ventricular end diastole anterior wall thickness | GCST90278518 | 1.19 |
| 5678 | KLK8/LY6D ratio | GCST90315257 | 1.19 |
| 5679 | Phosphatidylcholine (40:8) levels | GCST90024299 | 1.19 |
| 5680 | Pollinosis | GCST90018683 | 1.19 |
| 5681 | IDP dMRI TBSS ISOVF Posterior thalamic radiation R | GCST90004505 | 1.19 |
| 5682 | ABHD14B levels | GCST90468189 | 1.19 |
| 5683 | RAB2B levels | GCST90470406 | 1.18 |
| 5684 | Malignant melanoma | GCST90468141 | 1.18 |
| 5685 | APOF levels | GCST90468339 | 1.18 |
| 5686 | Neuroticism | GCST003770 | 1.18 |
| 5687 | DAB2 levels | GCST90468942 | 1.18 |
| 5688 | APP/LAMA4 ratio | GCST90313325 | 1.18 |
| 5689 | BCR/GOPC ratio | GCST90313491 | 1.18 |
| 5690 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T357 | ECGA000357 | 1.18 |
| 5691 | Takes medication for circulatory problem? | GCST90475218 | 1.18 |
| 5692 | F-acquired taste liking (derived food-liking factor) | GCST90094791 | 1.18 |
| 5693 | GDNF levels | GCST90274792 | 1.18 |
| 5694 | CD209/ITGAV ratio | GCST90313753 | 1.17 |
| 5695 | Cognition and processing speed (confirmatory factor analysis Factor 34) | GCST90309368 | 1.17 |
| 5696 | Waist-hip index | GCST90020027 | 1.17 |
| 5697 | BCL2L2 levels | GCST90422077 | 1.17 |
| 5698 | Cholesterol to total lipids ratio in small HDL | GCST90092945 | 1.17 |
| 5699 | Duration screen displayed | Prospective memory | UKBB00000201 | 1.17 |
| 5700 | RAB31 levels | GCST90087552 | 1.17 |
| 5701 | FXYD5/TMSB10 ratio | GCST90314906 | 1.17 |
| 5702 | IDP dMRI TBSS MD Posterior limb of internal capsule R | GCST90004045 | 1.17 |
| 5703 | Skin colour | Sun exposure | UKBB00000773 | 1.17 |
| 5704 | SNAP29 levels | GCST90470692 | 1.17 |
| 5705 | Mean corpuscular hemoglobin concentration | GCST90018745 | 1.17 |
| 5706 | IGFBP3 levels | GCST90102624 | 1.17 |
| 5707 | X-04499--3,4-dihydroxybutyrate levels | GCST90243497 | 1.17 |
| 5708 | ARSA/GUSB ratio | GCST90313355 | 1.17 |
| 5709 | GZMA/LTA ratio | GCST90315012 | 1.17 |
| 5710 | IDP dMRI TBSS OD Cerebral peduncle L | GCST90004417 | 1.17 |
| 5711 | RGMA/RGMB ratio | GCST90315769 | 1.17 |
| 5712 | Concentration of medium LDL particles | GCST90092911 | 1.17 |
| 5713 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T286 | ECGU000286 | 1.17 |
| 5714 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 1.17 |
| 5715 | RBFOX3 levels | GCST90470432 | 1.17 |
| 5716 | Primary/intrinsic cardiomyopathies (PheCode 425.1) | GCST90475951 | 1.16 |
| 5717 | Lysoalkylphosphatidylcholine (O-24:0) levels | GCST90025436 | 1.16 |
| 5718 | NPHS2 levels | GCST90470071 | 1.16 |
| 5719 | LAYN/VWC2 ratio | GCST90315293 | 1.16 |
| 5720 | LAYN/PTPRN2 ratio | GCST90315290 | 1.16 |
| 5721 | Reticulocyte count | GCST004622 | 1.16 |
| 5722 | Thyroid peroxidase antibody positivity in pregnancy | GCST90435202 | 1.16 |
| 5723 | IRAG2/TBC1D23 ratio | GCST90315191 | 1.16 |
| 5724 | rfMRI connectivity (ICA100 edge 961) | GCST90005814 | 1.16 |
| 5725 | AAMDC levels | GCST90468186 | 1.16 |
| 5726 | Polyarthropathies | FING00001180 | 1.16 |
| 5727 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 1.16 |
| 5728 | aparc-DKTatlas lh volume insula | GCST90002893 | 1.16 |
| 5729 | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | GCST90200103 | 1.16 |
| 5730 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 1.16 |
| 5731 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T414 | ECGA000414 | 1.16 |
| 5732 | IDP dMRI TBSS ISOVF Sagittal stratum R | GCST90004507 | 1.16 |
| 5733 | MPI levels | GCST90469936 | 1.16 |
| 5734 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T351 | ECGA000351 | 1.16 |
| 5735 | aparc-a2009s lh area G-precentral | GCST90003325 | 1.16 |
| 5736 | Psoriasis vulgaris | FING00001224 | 1.15 |
| 5737 | ICAM3 levels | GCST90469500 | 1.15 |
| 5738 | BAG3 levels | GCST90468416 | 1.15 |
| 5739 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T143 | ECGU000143 | 1.15 |
| 5740 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 1.15 |
| 5741 | UBXN1 levels | GCST90471004 | 1.15 |
| 5742 | Phospholipids to total lipids in small VLDL percentage (UKB data field 23599) | GCST90269696 | 1.15 |
| 5743 | IDP dMRI TBSS L2 Cingulum hippocampus L | GCST90004160 | 1.15 |
| 5744 | DYNLL1 levels | GCST90240984 | 1.15 |
| 5745 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T321 | ECGA000321 | 1.15 |
| 5746 | ANPEP levels | GCST90468313 | 1.15 |
| 5747 | IDP dMRI TBSS L2 Posterior corona radiata L | GCST90004150 | 1.15 |
| 5748 | MESD/VASH1 ratio | GCST90315425 | 1.15 |
| 5749 | CIAPIN1 levels | GCST90468753 | 1.15 |
| 5750 | Non-cancer illness code, self-reported - migraine | Medical conditions | UKBB00000520 | 1.15 |
| 5751 | ALOX15B levels | GCST90617547 | 1.14 |
| 5752 | Valine levels (UKB data field 23467) | GCST90269564 | 1.14 |
| 5753 | Melanocytic naevi of trunk | FING00000800 | 1.14 |
| 5754 | KLK6 levels | GCST90012008 | 1.14 |
| 5755 | DECR1/STX8 ratio | GCST90314452 | 1.14 |
| 5756 | ITGB1/MCAM ratio | GCST90315226 | 1.14 |
| 5757 | GRAP2/SNX9 ratio | GCST90314988 | 1.14 |
| 5758 | Mean bone marrow fat fraction of left and right proximal femur | GCST90652394 | 1.14 |
| 5759 | Hydrocele | FING00000627 | 1.14 |
| 5760 | FAS levels | GCST90427702 | 1.14 |
| 5761 | DTI TBSS L2 External capsule L | GCST90384509 | 1.14 |
| 5762 | Depression/anxiety (standard GWA) | GCST90267276 | 1.14 |
| 5763 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141 | ECGU000141 | 1.14 |
| 5764 | CYTL1 levels | GCST90468940 | 1.14 |
| 5765 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502581 | 1.14 |
| 5766 | AXIN1/INPPL1 ratio | GCST90313410 | 1.14 |
| 5767 | Middle diffusion tensor imaging along the perivascular space index | GCST90455544 | 1.13 |
| 5768 | CCL22 levels | GCST90240490 | 1.13 |
| 5769 | SMAD1 levels | GCST90470675 | 1.13 |
| 5770 | HSBP1 levels | GCST90469481 | 1.13 |
| 5771 | Weekly usage of mobile phone in last 3 months | Electronic device use | UKBB00000908 | 1.13 |
| 5772 | Eosinophil count | GCST90002381 | 1.13 |
| 5773 | DOK2 levels | GCST90469029 | 1.13 |
| 5774 | IL18BP levels | GCST90469564 | 1.13 |
| 5775 | CASP8 levels | GCST90468548 | 1.13 |
| 5776 | Phospholipid levels in medium LDL | GCST90092912 | 1.13 |
| 5777 | Pulse pressure (BMI unadjusted) | GCST90335166 | 1.13 |
| 5778 | EPS8L2/LGALS4 ratio | GCST90314685 | 1.13 |
| 5779 | NUCB2/TXNDC5 ratio | GCST90315578 | 1.13 |
| 5780 | aparc-a2009s rh area G-occipital-sup | GCST90003390 | 1.13 |
| 5781 | PSMG3 levels | GCST90470362 | 1.13 |
| 5782 | Sphingomyelin_36:2_[M+H]1+ levels | GCST90060263 | 1.13 |
| 5783 | Tea intake | Diet | UKBB00000814 | 1.13 |
| 5784 | AK2 levels | GCST90468270 | 1.13 |
| 5785 | Glomerular filtration rate in non diabetics (creatinine) | GCST003401 | 1.13 |
| 5786 | NCAN levels | GCST90618559 | 1.13 |
| 5787 | PLA2G4A/PPP1R12A ratio | GCST90315666 | 1.13 |
| 5788 | Eosinophil count | GCST90002298 | 1.12 |
| 5789 | IDP T1 FAST ROIs R postcent gyrus | GCST90002484 | 1.12 |
| 5790 | Lipoma of skin and subcutaneous tissue (PheCode 214.1) | GCST90475619 | 1.12 |
| 5791 | NECTIN2/NPDC1 ratio | GCST90315528 | 1.12 |
| 5792 | Coronary revascularization (ANGIO or CABG) | FING00000360 | 1.12 |
| 5793 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T410 | ECGA000410 | 1.12 |
| 5794 | IDP dMRI TBSS ISOVF Fornix | GCST90004482 | 1.12 |
| 5795 | AP1G2 levels | GCST90468323 | 1.12 |
| 5796 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T277 | ECGA000277 | 1.12 |
| 5797 | CRTAM/VCAM1 ratio | GCST90314281 | 1.12 |
| 5798 | Platelet count at delivery | GCST90302227 | 1.12 |
| 5799 | IDUA levels | GCST90469508 | 1.12 |
| 5800 | IGSF8/NECTIN2 ratio | GCST90315140 | 1.12 |
| 5801 | MOG levels | GCST90469929 | 1.12 |
| 5802 | Thyrotoxicosis with toxic multinodular goitre | FING00001362 | 1.12 |
| 5803 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31 | ECGU000031 | 1.12 |
| 5804 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T411 | ECGA000411 | 1.12 |
| 5805 | AKT3 levels | GCST90468278 | 1.12 |
| 5806 | High light scatter reticulocyte percentage | Blood count | UKBB00000327 | 1.11 |
| 5807 | BTN2A1/IL18BP ratio | GCST90313545 | 1.11 |
| 5808 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T391 | ECGU000391 | 1.11 |
| 5809 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T465 | ECGA000465 | 1.11 |
| 5810 | Birth weight | GCST007557 | 1.11 |
| 5811 | Back pain (PheCode 760) | GCST90476266 | 1.11 |
| 5812 | IDP dMRI TBSS MD Corticospinal tract R | GCST90004033 | 1.11 |
| 5813 | aparc-a2009s lh area G-pariet-inf-Supramar | GCST90003322 | 1.11 |
| 5814 | RSPO3 levels | GCST90470504 | 1.11 |
| 5815 | DTI autoptx L2 slf l tract | GCST90385187 | 1.11 |
| 5816 | CALCOCO1 levels | GCST90468530 | 1.10 |
| 5817 | DNA methylation PhenoAge acceleration | GCST90014292 | 1.10 |
| 5818 | ANPEP/NT5E ratio | GCST90313274 | 1.10 |
| 5819 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T389 | ECGU000389 | 1.10 |
| 5820 | HTRA2/SNAP29 ratio | GCST90315098 | 1.10 |
| 5821 | Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers) | FING00001330 | 1.10 |
| 5822 | FCRL2/SEMA7A ratio | GCST90314800 | 1.10 |
| 5823 | Glycerophosphorylcholine (GPC) levels | GCST90199629 | 1.10 |
| 5824 | Anti-human herpes virus 6 IE1A IgG seropositivity | GCST90006903 | 1.10 |
| 5825 | Rash and other nonspecific skin eruption (PheCode 687.1) | GCST90476167 | 1.10 |
| 5826 | DOK2/FADD ratio | GCST90314530 | 1.10 |
| 5827 | Polyarthrosis | FING00001181 | 1.10 |
| 5828 | Other diseases of the digestive system | FING00001010 | 1.10 |
| 5829 | OLR1 levels | GCST90012020 | 1.10 |
| 5830 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 62) | GCST90320625 | 1.10 |
| 5831 | CNTNAP4 levels | GCST90468809 | 1.10 |
| 5832 | Other disorders of synovium, tendon, and bursa (PheCode 727) | GCST90476241 | 1.10 |
| 5833 | IDP dMRI TBSS L1 Anterior corona radiata L | GCST90004098 | 1.10 |
| 5834 | Treatment speciality of consultant (recoded) - General surgery | Summary Administration | UKBB00000834 | 1.10 |
| 5835 | CD46/THBD ratio | GCST90313836 | 1.10 |
| 5836 | Multiple sclerosis | GCST90475833 | 1.09 |
| 5837 | Phenylacetate levels | GCST90199630 | 1.09 |
| 5838 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90025434 | 1.09 |
| 5839 | Glycated hemoglobin levels | GCST90566424 | 1.09 |
| 5840 | RNASEH2A levels | GCST90470480 | 1.09 |
| 5841 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284 | ECGU000284 | 1.09 |
| 5842 | Chronic ischaemic heart disease | Ischaemic heart diseases | UKBB00000137 | 1.09 |
| 5843 | Cardiomyopathy (PheCode 425) | GCST90475949 | 1.09 |
| 5844 | CETN2/TDRKH ratio | GCST90314031 | 1.09 |
| 5845 | BA-exvivo rh area BA1 | GCST90003221 | 1.09 |
| 5846 | Total lipid levels in lipoprotein particles | GCST90500086 | 1.09 |
| 5847 | STX8/USP8 ratio | GCST90315896 | 1.09 |
| 5848 | Lysophosphatidylcholine (22:6) [sn2] levels | GCST90024185 | 1.09 |
| 5849 | DTI TBSS L1 Anterior corona radiata R | GCST90384450 | 1.09 |
| 5850 | CD8 on Effector Memory CD8+ T cell | GCST90002056 | 1.09 |
| 5851 | Cough (PheCode 512.8) | GCST90476041 | 1.09 |
| 5852 | IDS levels | GCST90469507 | 1.09 |
| 5853 | DAPP1/ITGB1BP2 ratio | GCST90314388 | 1.09 |
| 5854 | Migraine | FING00000818 | 1.08 |
| 5855 | CA13 levels | GCST90468508 | 1.08 |
| 5856 | PHACTR2 levels | GCST90470224 | 1.08 |
| 5857 | MYOM2 levels | GCST90469985 | 1.08 |
| 5858 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T297 | ECGA000297 | 1.08 |
| 5859 | CHGA levels | GCST90468741 | 1.08 |
| 5860 | Multiple myeloma or monoclonal gammopathy of undetermined significance | GCST90624746 | 1.08 |
| 5861 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320672 | 1.08 |
| 5862 | NUDT2 levels | GCST90470106 | 1.08 |
| 5863 | DOK2/LACTB2 ratio | GCST90314532 | 1.08 |
| 5864 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231 | ECGU000231 | 1.08 |
| 5865 | CD27/NECTIN4 ratio | GCST90313775 | 1.08 |
| 5866 | IDP dMRI TBSS ICVF External capsule R | GCST90004359 | 1.08 |
| 5867 | Smoking status - Previous | Smoking | UKBB00000781 | 1.08 |
| 5868 | MPI/TACC3 ratio | GCST90315491 | 1.08 |
| 5869 | Left-hemisphere visual network to thalamus white-matter structural connectivity | GCST90302662 | 1.07 |
| 5870 | Cholesteryl ester_18:0_[M+NH4]1+ levels | GCST90060222 | 1.07 |
| 5871 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T297 | ECGU000297 | 1.07 |
| 5872 | PM: initial answer - Orange circle| Prospective memory | UKBB00000652 | 1.07 |
| 5873 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T295 | ECGU000295 | 1.07 |
| 5874 | MUC16 levels | GCST90469964 | 1.07 |
| 5875 | ENO1 levels | GCST90469109 | 1.07 |
| 5876 | NUBP1 levels | GCST90470100 | 1.06 |
| 5877 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 1.06 |
| 5878 | eosinophil (fraction, mean, inv-norm transformed) | GCST90475300 | 1.06 |
| 5879 | REG1A levels | GCST90470447 | 1.06 |
| 5880 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T397 | ECGA000397 | 1.06 |
| 5881 | IDP dMRI ProbtrackX ICVF ar l | GCST90004375 | 1.06 |
| 5882 | IL10 levels | GCST90469546 | 1.06 |
| 5883 | SEC31A levels | GCST90470563 | 1.05 |
| 5884 | aparc-pial rh area fusiform | GCST90003180 | 1.05 |
| 5885 | IL22 levels | GCST90469582 | 1.05 |
| 5886 | FABP1 levels | GCST90469173 | 1.05 |
| 5887 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90043977 | 1.05 |
| 5888 | Gastritis and duodenitis | digestive | UKBB00000277 | 1.05 |
| 5889 | IDP dMRI ProbtrackX L1 slf l | GCST90004267 | 1.05 |
| 5890 | ACVRL1 levels | GCST90468211 | 1.05 |
| 5891 | T1 FreeSurfer aseg Brain-Stem | GCST90384149 | 1.05 |
| 5892 | ATXN10/PRTFDC1 ratio | GCST90313398 | 1.05 |
| 5893 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T309 | ECGU000309 | 1.05 |
| 5894 | FLT1/VEGFA ratio | GCST90314858 | 1.05 |
| 5895 | Other chronic ischemic heart disease, unspecified | circulatory system | UKBB00000603 | 1.05 |
| 5896 | Oxalate (ethanedioate) levels | GCST90199672 | 1.05 |
| 5897 | PLAUR levels | GCST90012051 | 1.05 |
| 5898 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460 | ECGA000460 | 1.05 |
| 5899 | CLEC4D/MANSC1 ratio | GCST90314112 | 1.05 |
| 5900 | CALCOCO1/INPPL1 ratio | GCST90313603 | 1.05 |
| 5901 | IDP T1 FAST ROIs R cerebellum crus II | GCST90002574 | 1.05 |
| 5902 | General happiness | Happiness and subjective well-being | UKBB00000280 | 1.05 |
| 5903 | aparc-DKTatlas lh area caudalmiddlefrontal | GCST90003236 | 1.05 |
| 5904 | Degenerative skin conditions and other dermatoses (PheCode 702) | GCST90476202 | 1.04 |
| 5905 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T356 | ECGA000356 | 1.04 |
| 5906 | RELT levels | GCST90470453 | 1.04 |
| 5907 | IDP dMRI TBSS MO Pontine crossing tract | GCST90003953 | 1.04 |
| 5908 | PTGDS levels | GCST90470368 | 1.04 |
| 5909 | DTI TBSS L2 Tapetum L | GCST90384523 | 1.04 |
| 5910 | Eosinophill count | Blood count | UKBB00000206 | 1.04 |
| 5911 | HGF/TNFSF14 ratio | GCST90315060 | 1.04 |
| 5912 | Milk type used - Skimmed | Diet | UKBB00000470 | 1.04 |
| 5913 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93 | ECGA000093 | 1.04 |
| 5914 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T461 | ECGA000461 | 1.04 |
| 5915 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T221 | ECGA000221 | 1.04 |
| 5916 | FAM3B/FUT3_FUT5 ratio | GCST90314777 | 1.04 |
| 5917 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T412 | ECGA000412 | 1.04 |
| 5918 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 1.04 |
| 5919 | Gastritis and duodenitis | Diseases of oesophagus, stomach and duodenum | UKBB00000278 | 1.04 |
| 5920 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327 | ECGU000327 | 1.04 |
| 5921 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T353 | ECGA000353 | 1.04 |
| 5922 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328 | ECGU000328 | 1.04 |
| 5923 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T125 | ECGU000125 | 1.03 |
| 5924 | TNFAIP8L2 levels | GCST90470897 | 1.03 |
| 5925 | REST UKBBICA NODEamps25 0007 | GCST90385490 | 1.03 |
| 5926 | aparc-a2009s rh area S-parieto-occipital | GCST90003435 | 1.03 |
| 5927 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T29 | ECGU000029 | 1.03 |
| 5928 | Left bundle branch block (PheCode 426.32) | GCST90475958 | 1.03 |
| 5929 | EDAR levels | GCST90425556 | 1.03 |
| 5930 | X-12063 levels | GCST90243687 | 1.03 |
| 5931 | IDP dMRI ProbtrackX L2 cst l | GCST90004281 | 1.03 |
| 5932 | ESAM/JAM2 ratio | GCST90314712 | 1.03 |
| 5933 | Nonalcoholic fatty liver disease | GCST90275041 | 1.03 |
| 5934 | DKK1/VEGFA ratio | GCST90314483 | 1.03 |
| 5935 | CRADD levels | GCST90468854 | 1.03 |
| 5936 | ATP5IF1/DECR1 ratio | GCST90313382 | 1.03 |
| 5937 | EIF4G1 levels | GCST90469097 | 1.03 |
| 5938 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T293 | ECGA000293 | 1.03 |
| 5939 | Length of time at current address | Household | UKBB00000404 | 1.03 |
| 5940 | ICAM3/TNFRSF13B ratio | GCST90315124 | 1.03 |
| 5941 | ADAMTS16 levels | GCST90468224 | 1.03 |
| 5942 | Plasma argininate* levels in chronic kidney disease | GCST90264826 | 1.03 |
| 5943 | PCDHB15 levels | GCST90470173 | 1.03 |
| 5944 | Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594) | GCST90269691 | 1.03 |
| 5945 | TAX1BP1 levels | GCST90470808 | 1.03 |
| 5946 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T217 | ECGA000217 | 1.02 |
| 5947 | Left-hemisphere control network to pallidum white-matter structural connectivity | GCST90302755 | 1.02 |
| 5948 | Type 2 diabetes | GCST90086071 | 1.02 |
| 5949 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 1.02 |
| 5950 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T413 | ECGA000413 | 1.02 |
| 5951 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390 | ECGU000390 | 1.02 |
| 5952 | Skin cancer | GCST90475575 | 1.02 |
| 5953 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T98 | ECGU000098 | 1.02 |
| 5954 | RBP2 levels | GCST90470438 | 1.02 |
| 5955 | ANGPTL1 levels | GCST90468302 | 1.02 |
| 5956 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T301 | ECGA000301 | 1.02 |
| 5957 | Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive) | GCST90132227 | 1.02 |
| 5958 | Heterophoria | FING00000620 | 1.02 |
| 5959 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T365 | ECGU000365 | 1.02 |
| 5960 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T355 | ECGA000355 | 1.02 |
| 5961 | IDP T1 SIENAX grey normalised volume | GCST90002430 | 1.02 |
| 5962 | BLVRB/HAGH ratio | GCST90313524 | 1.01 |
| 5963 | Waist circumference | GCST90103753 | 1.01 |
| 5964 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464 | ECGA000464 | 1.01 |
| 5965 | Malignant neoplasm of liver, primary (PheCode 155.1) | GCST90475569 | 1.01 |
| 5966 | Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers) | FING00000764 | 1.01 |
| 5967 | Systemic lupus erythematosus | GCST90011866 | 1.01 |
| 5968 | wg rh intensity-contrast superiorfrontal | GCST90003854 | 1.01 |
| 5969 | BA-exvivo lh area BA4p | GCST90003212 | 1.01 |
| 5970 | Type of accommodation lived in - A house or bungalow | Household | UKBB00000869 | 1.01 |
| 5971 | EFNA4 levels | GCST90469081 | 1.01 |
| 5972 | FCRL3 levels | GCST90469207 | 1.01 |
| 5973 | DTI autoptx L1 ptr l tract | GCST90385158 | 1.01 |
| 5974 | Types of physical activity in last 4 weeks - None of the above | Physical activity | UKBB00000872 | 1.01 |
| 5975 | GZMH levels | GCST90469425 | 1.01 |
| 5976 | IDP dMRI ProbtrackX L1 ifo l | GCST90004258 | 1.01 |
| 5977 | Alcohol dependence | FING00000050 | 1.01 |
| 5978 | Takes medication for gout? | GCST90476382 | 1.01 |
| 5979 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T323 | ECGA000323 | 1.01 |
| 5980 | Keloid | GCST90652488 | 1.01 |
| 5981 | Tyrosine levels | GCST90200427 | 1.01 |
| 5982 | Use of hypnotics and sedatives | FING00001411 | 1.00 |
| 5983 | Encounter for long-term (current) use of anticoagulants (PheCode 286.2) | GCST90475799 | 1.00 |
| 5984 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421 | ECGU000421 | 1.00 |
| 5985 | Glomerular filtration rate (cystatin C) | GCST003375 | 1.00 |
| 5986 | Major depressive disorder (ICD-10 coded) | GCST005903 | 1.00 |
| 5987 | EFNA1 levels | GCST90469080 | 1.00 |
| 5988 | ADAMTS13 levels | GCST90468222 | 1.00 |
| 5989 | aparc-Desikan rh volume fusiform | GCST90002807 | 1.00 |
| 5990 | SNCA levels | GCST90470694 | 1.00 |
| 5991 | GABARAPL1 levels | GCST90469287 | 1.00 |
| 5992 | IDP dMRI TBSS OD Superior corona radiata R | GCST90004426 | 1.00 |
| 5993 | Diacylglycerol_44:7_[M+H-H2O]1+ levels | GCST90060240 | 1.00 |
| 5994 | Lesion of plantar nerve | FING00000720 | 1.00 |
| 5995 | Athlete's foot (PheCode 110.12) | GCST90475563 | 1.00 |
| 5996 | Parental longevity (both parents in top 10%) | GCST006698 | 1.00 |
| 5997 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T97 | ECGA000097 | 1.00 |
| 5998 | STX16 levels | GCST90470769 | 1.00 |
| 5999 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 1.00 |
| 6000 | DTI autoptx L3 str l tract | GCST90385216 | 1.00 |